Pharma Derasse BSI SRL
0.6 FTEPharma Derasse BSI reported total assets of 762,819 € at the end of the 2025 financial year (annual accounts filed with the NBB on 26 May 2026), with 0.6 full-time equivalent.
The score of Pharma Derasse BSI shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -1 % Total assets -16 % Headcount (avg FTE) -25 %
Accounts of the company itself (not consolidated).
The full file covers 4 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pharma Derasse BSI's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 26 May 2026
- Year ended 31 Dec 2024filed on 21 May 2025
- Year ended 31 Dec 2023filed on 05 Jun 2024
- Year ended 31 Dec 2022filed on 05 Jun 2023
Pharma Derasse BSI's financial analysis
- Solvency15.9%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pharma Derasse BSI
Pharma Derasse BSI's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0779.300.374
- VAT number
- BE0779300374
- Peppol
- Registered · 0208:0779300374 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 23 Dec 2021
- Registered office
- 1421 Braine-l'Alleud
- Size
- Micro · 0.6 FTE
- Latest accounts
- 2025 · filed on 26 May 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Pharma Derasse BSI (SRL) has been based in Braine-l'Alleud since 2021, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 9,055 € and equity of 120,966 €; its revenue is not published. With 0.6 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 15.9%, below the median of its sector (41.5%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Pharma Derasse BSI
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie BIHAIN Manufacture of basic pharmaceutical products Trois-Ponts · balance sheet 557,802 €
- Apotheek Larockstraat Retail sale of pharmaceutical products Anderlecht · balance sheet 724,107 €
- Boeyckens Retail sale of pharmaceutical products Vilvoorde · balance sheet 713,576 €
- Proxypharma LLB Retail sale of pharmaceutical products La Bruyère · balance sheet 707,554 €
- License to care Retail sale of pharmaceutical products Duffel · balance sheet 702,743 €
- Pharmaflor Retail sale of pharmaceutical products Namur · balance sheet 831,466 €
- Haelvoetpharma Retail sale of pharmaceutical products Evere · balance sheet 906,520 €
Frequently asked questions about Pharma Derasse BSI
What is the revenue of Pharma Derasse BSI?
Pharma Derasse BSI files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Pharma Derasse BSI?
In Belgium, the VAT number is the company number prefixed with BE: BE0779300374 for Pharma Derasse BSI, if the company is VAT-registered. Its company number (CBE) is 0779.300.374.
Where is the registered office of Pharma Derasse BSI?
According to the CBE register, the registered office of Pharma Derasse BSI is in 1421 Braine-l'Alleud.
What is the equity of Pharma Derasse BSI?
At the close of the 2025 financial year, the equity of Pharma Derasse BSI amounts to 120,966 €, a solvency of 15.9% of total assets.
How many people work at Pharma Derasse BSI?
0.6 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Pharma Derasse BSI?
The register lists 1 active mandates at Pharma Derasse BSI. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Pharma Derasse BSI
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →